STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial
Status:
Terminated
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that granulocyte colony-stimulating factor
(G-CSF) therapy in addition to state-of-the-art treatment (pharmacological and non
pharmacological) is safe and significantly improves clinical outcome in patients with reduced
left ventricular ejection fraction (LVEF) (≤45%) after successful reperfusion for large
anterior acute myocardial infarction.